Fmr LLC Kaleido Biosciences, Inc. Transaction History

Fmr LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.05 - $1.7 $319,483 - $10.9 Million	-6,389,660 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.3 - $2.7 $660 - $1,371	508 Added 0.01%	6,389,660 $10.5 Million
Q4 2021 Feb 14, 2022	BUY	$2.39 - $6.02 $6,029 - $15,188	2,523 Added 0.04%	6,389,152 $15.3 Million
Q3 2021 Nov 15, 2021	BUY	$5.36 - $7.99 $47,339 - $70,567	8,832 Added 0.14%	6,386,629 $34.9 Million
Q2 2021 Aug 13, 2021	BUY	$5.82 - $8.72 $37.1 Million - $55.6 Million	6,377,797 New	6,377,797 $47.5 Million

2.3K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

Stay updated on Fmr LLC with notifications on news.